LifeScience PLUS, Inc.

What LifeScience PLUS, Inc. does

LifeScience PLUS, Inc. is a Mountain View, California-based privately held medical device company founded in 2005 that develops and markets hemostatic wound care products built on a proprietary etherified carboxymethyl cellulose (eCMC) platform. The eCMC technology is a 100% plant-based, water-soluble matrix that transforms into a gel upon contact with blood or exudates, activating the intrinsic coagulation cascade to accelerate clot formation and modulating the Wnt/Frizzled cellular signaling pathway to promote tissue regeneration. The product portfolio spans the flagship BloodSTOP iX Advanced Hemostat with WoundHEAL, the larger-format BloodSTOP iX Trauma Matrix (FDA 510(k) cleared in May 2026 for severe bleeding), DonorSeal (a donor-site dressing launched in April 2024), the original BloodSTOP Hemostatic Dressing, an OTC consumer line, the WoundFLEX compression adjunct, and the ARC X-SP extremity stabilizer positioner.

The company operates a multi-channel go-to-market: independent 1099 medical sales representatives cover US hospital, trauma, EMS, and dental accounts; major distributors include Henry Schein, McKesson, Patterson Dental, and Benco Dental; consumer SKUs are sold at Walgreens, CVS, and Amazon; and government sales flow through GSA Schedule #V797D-70261 and DLA-DAPA SP0200-16-H-0005. International distribution is anchored by a partnership with KITSS Therapeutics for Ghana and Liberia, with documented clinical use in Uzbekistan. Revenue is generated through one-time product purchase with no recurring subscription component, and prices range from $16.99 for OTC boxes to $768 for professional trauma kits. The customer base spans acute care hospitals, burn centers, dental practices, EMS and military first responders, and consumers, with named accounts including Kindred Hospital, Long Beach Memorial, Nicklaus Children's Hospital, Jacobi Burn Center, Brighton ENT Australia, and the Republican Scientific-Practical Medical Center of Neurosurgery in Uzbekistan. The company is founder-led by CEO and President Vicky Feng-Grubb and operates with a team of 11-50 employees; no institutional funding rounds, acquisitions, or public-market exposure are disclosed.

Name

LifeScience PLUS, Inc.

Legal name

LifeScience PLUS, Inc.

Website

https://lifescienceplus.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

LifeScience PLUS is a privately held Mountain View, California medical device company that develops plant-based hemostatic wound dressings using proprietary etherified carboxymethyl cellulose (eCMC), serving hospitals, trauma and EMS teams, dental clinics, and consumers globally.

Ownership category

akta.pro rank

Product category

Advanced Wound Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)

akta.pro secondary industries

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL), First Aid & Wound Care (HLAIADAM)

Keywords

• Hemostatic wound dressings
• Advanced wound care
• Hemorrhage control devices
• Trauma care products
• Burn care solutions

Headquarters

HQ city

Mountain View

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Product Sales: LifeScience PLUS generates revenue through the sale of its hemostatic wound care products including BloodSTOP iX, BloodSTOP, DonorSeal, and WoundFLEX. Products are sold in various sizes and configurations at different price points ranging from $16.99 for basic OTC products to $768 for professional boxes. Revenue is primarily one-time product purchase with no recurring subscription component.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels7 records

Core offering

LifeScience PLUS develops, manufactures, and markets advanced hemostatic wound care products based on its proprietary Etherified Carboxymethyl Cellulose (eCMC) technology. The product portfolio includes the flagship BloodSTOP iX Advanced Hemostat with WoundHEAL for professional medical use, BloodSTOP iX Trauma Matrix for severe bleeding control, DonorSeal for donor site care, BloodSTOP Hemostatic Dressing for surface wounds, BloodSTOP OTC for consumer first aid, WoundFLEX Compression Dressing, and the Arc Extremity Stabilizer Positioner. Products are sold to hospitals, trauma/burn centers, dental practices, EMS/military, and consumers through medical distributors, retail pharmacies, government contracts, and direct e-commerce.

Product overview

LifeScience PLUS offers a comprehensive portfolio of advanced wound care products centered on its proprietary etherified carboxymethyl cellulose (eCMC) technology platform. The core product family includes BloodSTOP iX Advanced Hemostat with WoundHEAL for medical professionals, the larger-format BloodSTOP iX Trauma Matrix for severe bleeding control, and the original BloodSTOP Hemostatic Dressing for surface wounds. Supporting products include DonorSeal for donor site wound care, BloodSTOP OTC for consumer/over-the-counter use, and WoundFLEX Compression Dressing as an adjunctive compression layer. The Arc Extremity Stabilizer Positioner provides hands-free surgical positioning support. All products in the portfolio share the plant-based, water-soluble eCMC technology that transforms upon contact with blood to form a gel barrier, accelerate clotting, and create moist wound healing environments.

Differentiator

Problem solved

Functional benefit

Brands

• BloodSTOP: Hemostatic dressing product line for surface wound care, made from water-soluble etherified carboxymethyl cellulose.
• BloodSTOP iX Advanced Hemostat with WoundHEAL
• BloodSTOP iX Trauma Matrix
• DonorSeal
• WoundFLEX Compression Dressing
• Arc Extremity Stabilizer Positioner (ARC X-SP)

Products and services

• BloodSTOP iX Advanced Hemostat with WoundHEAL Clinically proven hemostatic dressing and wound healing matrix made from 100% plant-based etherified carboxymethyl cellulose (eCMC). Provides rapid hemorrhage control, accelerates clot formation via intrinsic coagulation cascade activation, and promotes tissue regeneration through Wnt/Frizzled cellular signaling pathway activation. Designed for medical professionals in hospital, surgical, trauma, burn, dental, and chronic wound applications.
• BloodSTOP iX Trauma Matrix Advanced hemostat specifically designed for traumatic bleeding control in military, prehospital, and burn/trauma care. Larger sizes effectively meet hemorrhage control needs during long transport. Demonstrated 100% survival rate on extremity arterial hemorrhage in swine model using U.S. military standard trauma injury protocol, with significantly shorter times to hemostasis versus Combat Gauze control.
• DonorSeal Breakthrough hemostatic and wound healing dressing specifically designed for donor sites. Part of the eCMC technology family, providing rapid hemorrhage control, blood loss reduction, wound healing promotion, and donor site comfort with pH-neutral, soothing coverage. A registered trademark of LifeScience PLUS.
• BloodSTOP Hemostatic Dressing Patented hemostatic matrix made from water soluble etherified carboxymethyl cellulose for surface wound care. Approved for patients taking anticoagulant medications with EU CE certification and FDA market clearance for surface wound hemostasis. Priced $44.00-$203.50 per box depending on size and quantity.
• BloodSTOP OTC (Over-the-Counter) Over-the-counter bleeding control dressing available at retail locations. Water soluble dressing that stops bleeding fast, turns into transparent gel to seal wounds, prevents contamination, and creates moist healing environment. Available at Walgreens, CVS, Amazon, and through company e-commerce at $16.99 per box of 10 pieces.
• WoundFLEX Compression Dressing Flexible, stretchable, sterile compression dressing designed for adjunctive compression over BloodSTOP iX hemostatic dressings. Provides uniform pressure to seal wounds evenly, accelerates clotting process, and protects fragile skin. Non-adherent surface allows removal without disrupting clot. A registered trademark of LifeScience PLUS.
• Arc Extremity Stabilizer Positioner (ARC X-SP) Hands-free solution for positioning extremities during burn treatment and orthopedic surgeries. Made with lightweight aluminum-plate and stainless steel with 13 evenly spaced hooks for positioning flexibility using Adair Tissue Holding Tenaculum Forceps.

Quantifiable outcome

• 100% survival rate in extremity arterial hemorrhage in swine model vs Combat Gauze control
• +7 more outcomes

Named customers10 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• KITSS TherapeuticscoreChannel Partner/ Reseller/ Distributor · 1 May 2023Partnership with KITSS Therapeutics for introduction of BloodSTOP iX Advanced Hemostat to Ghana and Liberia. KITSS Therapeutics serves as distribution partner for West African markets, expanding access to revolutionary wound care technology in developing regions.
• Wilson Sonsini Goodrich & RosatiminorOthersLifeScience PLUS legal counsel providing legal representation and guidance.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Z-Medica (QuikClot): Acquired by Teleflex, Z-Medica makes QuikClot Combat Gauze, the leading hemostatic gauze used by the US military. Direct competitor to BloodSTOP iX Trauma Matrix in the same prehospital/trauma channel with similar mechanism categories and government contracting.
• Tricol Biomedical (HemCon): Tricol/HemCon produces chitosan-based hemostatic dressings (HemCon bandage, Celox) for military and civilian trauma. Closest direct peer to LifeScience PLUS in plant-/natural-polymer hemostatic gauze with comparable military and first-responder channels.

Broad incumbents

• Baxter International (Floseal): Baxter's Floseal hemostatic matrix is used in surgical settings and overlaps with BloodSTOP iX in surgical hemostasis. Baxter is a large diversified medical-products incumbent with the sales coverage and GPO relationships LifeScience PLUS lacks.
• Ethicon (Johnson & Johnson): Ethicon makes Surgicel, Fibrillar, and other oxidized cellulose hemostatic products that LifeScience PLUS explicitly positions against on price and performance. Direct competitor in OR hemostasis with deeply entrenched surgical-specialty relationships.
• Integra LifeSciences: Integra has a broad wound care and surgical hemostasis portfolio (e.g., Surgimend, Integra dermal matrix) and competes with BloodSTOP in hospital wound care and surgical applications. Larger incumbent with established hospital sales infrastructure.
• Smith & Nephew: Global wound care leader (Acticoat, Allevyn, PICO) competing across advanced wound care and burn dressings. Overlaps with BloodSTOP in chronic wound care, burn surgery, and surgical wound management channels.
• Becton Dickinson (BD): BD has surgical hemostasis and biosurgery products (e.g., Avitene, Surgifoam) that compete with BloodSTOP iX in the OR. Diversified med-tech incumbent with significant hospital procurement leverage.
• ConvaTec: ConvaTec's advanced wound care portfolio (Avelle, Aquacel, DuoDERM) overlaps with LifeScience PLUS's chronic-wound-care and burn applications. Larger incumbent competing for the same hospital and home-care wound-care customers.

Emerging players

• Arch Therapeutics: Arch's AC5 self-assembling peptide hemostatic technology targets the same surgical/trauma hemostasis niche as BloodSTOP iX. Comparable small-cap, single-platform, FDA-cleared wound-sealant company competing for similar specialty adoption.
• Marine Polymer Technologies: Developer of poly-N-acetyl glucosamine (pGlcNAc) hemostatic and wound-healing technologies (e.g., Syvek, Talymed). Comparable small, science-driven company with natural-polymer hemostatic products targeting surgical and wound-care use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BloodSTOP
• YouTubeyoutube.com/c/LifeSciencePLUS
• Facebookfacebook.com/BloodSTOP
• LinkedInlinkedin.com/company/1007416
• Instagraminstagram.com/lifescienceplus

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeScience PLUS, Inc.